About Matthew Williams
Form D filings for SignalRX Pharmaceuticals in 2023 list Matthew Williams as director and chief executive officer.
Matthew Williams first appears on SEC filings in 2023.
Experience
This experience comes from SEC filings. The years are when the filings name Matthew Williams in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Matthew Williams works with at each company, as listed on that company's latest Form D.
SignalRX Pharmaceuticals, Inc · Form D, May 3, 2023
GM
Guillermo Morales
Director
JW
Joel Wernick
Director